Dr. Saif Ahmad is an MD-PhD cancer clinician with over 15 years’ experience, and researcher based at the University of Cambridge. He is an honorary Consultant Clinical Oncologist at Addenbrooke’s Hospital and his research has been featured in The New York Times, BBC News and as the cover article of the British Medical Journal, and he has co-authored an article with the US FDA on radiotherapy-drug combinations.
Dr. Ahmad serves as an Assistant Editor on the Royal College of Radiologists’ Clinical Oncology Journal. In addition, he has served on expert advisory panels at AstraZeneca and NHSx, the organisation responsible for setting the NHS’s setting digitisation strategy. He is also an NHS Clinical Entrepreneur, and an Innovation Fellow of the Canada-UK Foundation.
In 2018, he co-founded 52 North Health, which is creating a point-of-care diagnostic for use in cancer patients at risk of neutropenic sepsis, and he continues to serve as its Chief Scientific and Medical Officer.